European Journal of Clinical Pharmacology

, Volume 35, Issue 1, pp 77–79 | Cite as

Protective effect of tulobuterol on methacholine-induced bronchospasm in asthmatic children

  • A. Riba
  • R. Dal-Re
  • F. Morell
Short Communications
  • 19 Downloads

Summary

In a single-blind, placebo-controlled trial 19 asthmatic children aged 10–14 years were studied during a stable phase of the disease. All patients were tested with a methacholine inhalation test on two consecutive days, on the first day after oral administration of a placebo, and on the second day following an oral dose of tulobuterol HCl.

The cumulative methacholine dose required to produce at least a 20% decrease in FEV1 was significantly higher after tulobuterol than after the placebo.

It is concluded that tulobuterol HCl reduces methacholine-induced bronchospasm in children.

Key words

tulobuterol asthma methacholine inhalation children 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nelson HS (1982) Beta-adrenergic agonists. Chest 82 [Suppl]: 33S-38SGoogle Scholar
  2. 2.
    Galant GP (1983) Current status of beta-adrenergic agonists in bronchial asthma. Pediatr Clin North Am 30: 931–941Google Scholar
  3. 3.
    Webb J, Rees J, Clark TJH (1982) A comparison of the effects of different methods of administration of beta2-sympathomimetics in patients with asthma. Br J Dis Chest 76: 351–357Google Scholar
  4. 4.
    Townley RC, Bewta AK, Nair NM, Brodkey FD, Watt BD, Burke KM (1979) Methacholine inhalation challenge studies. J Allergy Clin Immunol 64: 569–574Google Scholar
  5. 5.
    Easton JG, Hirata I (1983) Patterns of response to inhaled methacholine. Ann Allergy 50: 171–173Google Scholar
  6. 6.
    Pratter MR, Irwin RS (1984) The clinical value of pharmacologic bromchoprovocation challenge. Chest 85: 260–265Google Scholar
  7. 7.
    Woenne R, Kattan M, Orange RP, Levison H (1978) Bronchial hyperactivity to histamine and methacholine in asthmatic children after inhalation of SCH 1000 and chlorpheniramine maleate. J Allergy Clin Immunol 62: 119–124Google Scholar
  8. 8.
    Kubo S, Kase Y, Miyata T, Kito G, Uesaka J (1975) Pharmacological studies of 1-(o-chlorophenyl)-2-tert-1butylamino-ethanol (C-78), a new bronchodilator. Arzneimittelforsch 25: 1028–1037Google Scholar
  9. 9.
    Patel KR (1985) Tulobuterol in the management of obstructive airways disease in adults. Clin Ther 7: 452–467Google Scholar
  10. 10.
    Chatham M, Bleecker ER, Norman P, Smith PL, Mason P (1982) A screening test for airways reactivity. An abbreviated methacholine inhalation challenge. Chest 82: 15–18Google Scholar
  11. 11.
    Kubo S, Uesaka I, Matsubara I, Ishihara T, Kase Y (1977) Pharmacological studies of o-chloro-alfa-(tert.butylamino)-methyl benzylalcohol hydrochloride (C-78), a new bronchodilator. Arzneimittelforsch 27: 1433–1439Google Scholar
  12. 12.
    Laorden ML, Hernandez J, Brugger AJ (1985) The beta-agonist drug tulobuterol decreases cardiac automacity in the rat: Comparison with isoproterenol. Gen Pharmacol 16: 65–67Google Scholar
  13. 13.
    Kobayashi N, Nakayama Y, Baba (1981) Clinical effects of newly developed bronchodilator tulobuterol (C-78) on infantile bronchial asthma. Results of double-blind comparison test on patients at Nationwide institutions. Japn J Pediatr Med 13: 471–493Google Scholar
  14. 14.
    Maesen F, Smeets J, Polderman J (1983) A comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction. Arzneimittelforsch 33: 1696–1698Google Scholar
  15. 15.
    Kabasawa Y, Hiraide M, Marsuoka Y, Murata H (1983) Suppression of exercise-induced bronchoconstriction by beta-stimulant, tulobuterol HCl. A study by repeated exercise loading with treadmill. J Pediatr Pract 46: 861–865Google Scholar
  16. 16.
    Patel KR (1986) Bronchodilator activity of a new inhaled beta2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma. Br J Clin Pharmacol 21: 1–4Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • A. Riba
    • 1
  • R. Dal-Re
    • 2
  • F. Morell
    • 1
  1. 1.Pulmonary Section, General Hospital Vall d'HebronAutonomous UniversityBarcelonaSpain
  2. 2.Medical DepartmentAbbott Laboratories S.A.MadridSpain

Personalised recommendations